文献速递系统性红斑狼疮

专家视角:临床挑战——狼疮与妊娠

Expert Perspective on a Clinical Challenge: Lupus and Pregnancy.
PubMed 文献 · Arthritis Rheumatol · 2024-01-09

本文综述系统性红斑狼疮(SLE)女性孕前规划与妊娠期管理的现有知识。孕前数月达到缓解或低疾病活动度并使用妊娠兼容药物,是降低疾病复发和改善妊娠结局(包括子痫前期、早产、宫内生长受限)的关键;孕前及孕期疾病控制良好并密切管理时,不足10%的患者复发。

要点

  • 所有SLE患者除非禁忌均应继续使用羟氯喹。
  • 有抗磷脂综合征史者孕期应接受抗凝治疗;抗Ro/SSA或抗La/SSB抗体阳性者需额外监测胎儿先天性心脏传导阻滞。
  • SLE患者应在孕早期末开始低剂量阿司匹林以降低子痫前期风险;霉酚酸酯/霉酚酸、甲氨蝶呤、来氟米特和环磷酰胺禁用于妊娠。

核心结论

  • 孕前数月使用妊娠兼容药物达到缓解或低疾病活动度,对降低疾病复发风险和改善妊娠结局至关重要。
  • 在孕前及孕期密切管理且疾病控制良好的情况下,不足10%的患者复发。
  • 狼疮女性妊娠结局总体在改善,但最佳管理策略的知识空白仍存在。

研究设计与样本

  • 本文为综述,总结SLE孕前规划与妊娠期管理的现有知识。

主要发现

  • 孕前达到缓解或低疾病活动度可降低疾病复发风险并改善妊娠结局,包括子痫前期、早产和宫内生长受限。
  • 孕前及孕期密切管理且疾病控制良好时,不足10%的患者复发。
  • 有抗磷脂综合征史的孕妇孕期应接受抗凝治疗。
  • 抗Ro/SSA或抗La/SSB抗体阳性的女性所生子女发生先天性心脏传导阻滞的风险增加,需额外监测。
  • 孕期鉴别狼疮肾炎复发与子痫前期可能尤其困难。

关键数值与推荐

  • 所有SLE患者除非禁忌均应继续使用羟氯喹。
  • 有抗磷脂综合征史者孕期应接受抗凝治疗。
  • 抗Ro/SSA或抗La/SSB抗体阳性者需额外监测,因其子女先天性心脏传导阻滞风险增加。
  • SLE患者应在孕早期末开始低剂量阿司匹林以降低子痫前期风险。
  • 硫唑嘌呤、他克莫司和环孢素与妊娠兼容,生物制剂也可考虑;糖皮质激素应限制在最低有效剂量;霉酚酸酯/霉酚酸、甲氨蝶呤、来氟米特和环磷酰胺有致畸性,禁用于妊娠。

临床怎么用

  • 孕前应使用妊娠兼容药物使疾病达到缓解或低疾病活动度并维持数月。
  • 孕期SLE复发需要升级治疗。
  • 妊娠期糖皮质激素应限制在最低有效剂量。

局限性

  • 最佳管理策略的知识空白仍存在。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Systemic lupus erythematosus (SLE), a multiorgan systemic inflammatory disorder, predominantly affects women during their reproductive years. In this review, we summarize the state of knowledge about preconception planning and management of SLE during pregnancy. Achieving remission or low disease activity for several months on medications compatible with pregnancy prior to conception is essential to decreasing the risk of disease flare and improving pregnancy outcomes, including pre-eclampsia, preterm birth, and intrauterine growth restriction. With close management and well-controlled disease before and during pregnancy, <10% of patients flare. All patients with SLE should remain on hydroxychloroquine unless contraindicated. Expectant mothers with a history of antiphospholipid syndrome should be treated with anticoagulant therapy during pregnancy. Women with anti-Ro/SSA or anti-La/SSB antibodies require additional monitoring because their offspring are at increased risk for congenital heart block. Patients with SLE should be offered low-dose aspirin starting at the end of the first trimester to reduce the risk of pre-eclampsia. Flares of SLE during pregnancy require escalation of therapy. The immunosuppressives azathioprine, tacrolimus, and cyclosporine are compatible with pregnancy, and biologic agents can also be considered. Glucocorticoid use in pregnancy should be limited to the lowest effective dose. Mycophenolate mofetil/mycophenolic acid, methotrexate, leflunomide, and cyclophosphamide are known to be teratogenic and are contraindicated in pregnancy. Distinguishing a flare of lupus nephritis during pregnancy from pre-eclampsia can be particularly challenging. Overall, outcomes in pregnancy for women with lupus are improving, but gaps in knowledge about optimal management strategies persist.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Tarter L, Bermas BL. Expert Perspective on a Clinical Challenge: Lupus and Pregnancy. Arthritis Rheumatol. 2024. PMID: 37975160. doi:10.1002/art.42756

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。